Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, P. R. China.
Department of Liver Surgery, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, P. R. China.
BMC Cancer. 2023 Feb 27;23(1):193. doi: 10.1186/s12885-023-10630-x.
Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient.
Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed.
A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR.
Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery.
This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446).
腹腔镜肝切除术(LLR)现已广泛应用于治疗原发性肝癌(PLC),其长期疗效与开腹肝切除术(OLR)相当,短期疗效更优。对于可切除的 PLC(rPLC),最佳手术方法仍存在争议。在此,我们旨在开发一个列线图来确定个体患者最合适的切除方法。
回顾了 2013 年 1 月至 2018 年期间接受肝切除术的 rPLC 患者。构建了 LLR 中高危手术的预测模型。
在 LLR 组中纳入了 900 例患者,在 OLR 组中纳入了 423 例患者。既往抗肿瘤治疗史、肿瘤直径、肿瘤位置和切除范围与 LLR 的高危手术独立相关。基于这些危险因素构建的列线图在发展队列中预测高危手术的准确性较好,C 指数为 0.83,验证队列为 0.76。如果计算得分大于 0.8、在 0.2 和 0.8 之间或小于 0.2,则将患者分为接受 LLR 的高、中或低风险水平。与接受 OLR 的患者相比,行 LLR 的高风险患者出血量更多(441ml 至 417ml),手术时间更长(183min 至 150min)。
将 LLR 高危患者改为接受 OLR 以降低手术风险和并发症,将 LLR 低危患者改为接受 LLR 以最大限度地发挥微创手术的优势。
本研究在中国临床试验注册中心(注册号:ChiCTR2100049446)注册。